PAPER Dewachter I, Van Dorpe J, Spittaels K, Tesseur I, Van den Haute C, Moechars D, Van Leuven F

Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.

Exp Gerontol. 2000 Sep;35(6-7):831-41. PubMed: 11053674

PAPER Kienlen-Campard P, Tasiaux B, Octave JN

The processing and biological function of the human amyloid precursor protein (APP): lessons from different cellular models.

Exp Gerontol. 2000 Sep;35(6-7):843-50. PubMed: 11053675

PAPER Corder EH, Woodbury MA, Volkmann I, Madsen DK, Bogdanovic N, Winblad B

Density profiles of Alzheimer disease regional brain pathology for the huddinge brain bank: pattern recognition emulates and expands upon Braak staging.

Exp Gerontol. 2000 Sep;35(6-7):851-64. PubMed: 11053676

PAPER Kok CC, Boyt A, Gaudieri S, Martins R, Askanas V, Dalakas M, Kiers L, Mastaglia F, Garlepp M

Mitochondrial DNA variants in inclusion body myositis.

Neuromuscul Disord. 2000 Dec;10(8):604-11. PubMed: 11053689

PAPER Lovell MA, Xie C, Markesbery WR

Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures.

Free Radic Biol Med. 2000 Oct 15;29(8):714-20. PubMed: 11053772

PAPER Savaskan E, Müller-Spahn F, Olivieri G, Bruttel S, Otten U, Rosenberg C, Hulette C, Hock C

Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease.

Eur Neurol. 2000;44(3):172-80. PubMed: 11053967

PAPER Castillo GM, Lukito W, Peskind E, Raskind M, Kirschner DA, Yee AG, Snow AD

Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.

J Neurosci Res. 2000 Nov 1;62(3):451-62. PubMed: 11054814

PAPER Flaherty DB, Soria JP, Tomasiewicz HG, Wood JG

Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants.

J Neurosci Res. 2000 Nov 1;62(3):463-72. PubMed: 11054815

PAPER Schindler RJ, Cucio CP

Late-life dementia. Review of the APA guidelines for patient management.

Geriatrics. 2000 Oct;55(10):55-60; quiz 62. PubMed: 11054951

PAPER Macknight C

World Alzheimer Congress 2000.

Clin Invest Med. 2000 Oct;23(5):339-41. PubMed: 11055327

PAPER Ksiezak-Reding H, He D, Gordon-Krajcer W, Kress Y, Lee S, Dickson DW

Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes.

Cell Motil Cytoskeleton. 2000 Nov;47(3):236-52. PubMed: 11056524

PAPER Steiner H, Kostka M, Romig H, Basset G, Pesold B, Hardy J, Capell A, Meyn L, Grim ML, Baumeister R, Fechteler K, Haass C

Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases.

Nat Cell Biol. 2000 Nov;2(11):848-51. PubMed: 11056541

PAPER Chu LW, Chiu KC, Hui SL, Yu GK, Tsui WJ, Lee PW

The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong.

Ann Acad Med Singapore. 2000 Jul;29(4):474-85. PubMed: 11056778

PAPER Korczyn AD

Muscarinic M(1) agonists in the treatment of Alzheimer's disease.

Expert Opin Investig Drugs. 2000 Oct;9(10):2259-67. PubMed: 11060805

PAPER Sramek JJ, Frackiewicz EJ, Cutler NR

Review of the acetylcholinesterase inhibitor galanthamine.

Expert Opin Investig Drugs. 2000 Oct;9(10):2393-402. PubMed: 11060814